Dawn F. Ionescu

Double-blind, placebo-controlled, dose-ranging trial of intravenous ketamine as adjunctive therapy in treatment-resistant depression (TRD)

Maurizio Fava, Marlene P. Freeman, Martina Flynn et al. · Molecular Psychiatry · 2018 · 437 citations · Full text

Medicine, Pharmacology, Psychiatry +16

Esketamine Nasal Spray for Rapid Reduction of Depressive Symptoms in Patients With Major Depressive Disorder Who Have Active Suicide Ideation With Intent: Results of a Phase 3, Double-Blind, Randomized Study (ASPIRE II)

Dawn F. Ionescu, Dong‐Jing Fu, Xin Qiu et al. · The International Journal of Neuropsychopharmacology · 2020 · 409 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Esketamine Nasal Spray for Rapid Reduction of Major Depressive Disorder Symptoms in Patients Who Have Active Suicidal Ideation With Intent

Dong‐Jing Fu, Dawn F. Ionescu, Xiang Li et al. · The Journal of Clinical Psychiatry · 2020 · 366 citations · Full text

Medicine, Pharmacology, Psychiatry +17

Improvement in suicidal ideation after ketamine infusion: Relationship to reductions in depression and anxiety

Elizabeth D. Ballard, Dawn F. Ionescu, Jennifer L. Vande Voort et al. · Journal of Psychiatric Research · 2014 · 285 citations

Medicine, Pharmacology, Psychiatry +14

Do the dissociative side effects of ketamine mediate its antidepressant effects?

David A. Luckenbaugh, Mark J. Niciu, Dawn F. Ionescu et al. · Journal of Affective Disorders · 2014 · 282 citations · Full text

Medicine, Pharmacology, Psychiatry +16